Lv3
358 积分 2025-03-26 加入
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
1天前
待确认
The Current and Future Management of Malignant Ascites
18天前
已完结
Advances in the treatment of malignant ascites in China
1个月前
已完结
Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy
1个月前
已完结
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
1个月前
已完结
Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant
1个月前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
1个月前
已完结
Epidermal Growth Factor Receptor Expression and Gene Copy Number in Conventional Hepatocellular Carcinoma
2个月前
已完结
Expression of c-Met in Primary and Recurrent Hepatocellular Carcinoma
2个月前
已完结
Met, metastasis, motility and more
2个月前
已完结
皖公网安备34019202002308
